One isolate per patient was included in the study. The isolates were stored in glycerol stocks at 70°C, and re-cultured on Löwenstein-Jensen (LJ) media for 4-6 weeks at 37°C before further testing. Identification of the isolates was verified by the GenoType MTBC assay (Hain Lifescience, https://www.hain-lifescience.de/en/). DST for first-(except pyrazinamide (PZA)) and second-line drugs was performed with the indirect proportion method on LJ slants using World Health Organization (WHO) recommended critical concentrations during 2008-2011, and as described previously (1). PZA was tested in MGIT960 according to the manufacturer instructions and at WHO recommended critical concentrations. From 2012 onward, all drugs, except cycloserine (CS) and para-aminosalicylic acid (PAS), were tested in MGIT960. Both CS and PAS were still tested on LJ slants at 30 mg/L, and 1 mg/L with the indirect proportion method as recommended that time.
completed following the manufacturer's tissue protocol (from step 4).
Whole-Genome Sequencing (WGS)
DNA library preparation was performed according to the Nextera XT manufacturer instructions (Illumina, http://www.illumina.com). Sequencing was carried out with the Illumina MiSeq and HiSeq system with a minimum average coverage depth of 50-fold. Fastq files have been submitted to the European Nucleotide Archive (ENA);accession numbers are given in Appendix 2. Resulting reads were mapped to the M. tuberculosis H37Rv genome (GenBank accession no. NC_000962.3) using BWA-MEM (2) , and mappings refined with the GATK software package (3) .
Variants were detected with Samtools (4) and filtered with perl scripts for thresholds of a minimum coverage of 4 reads in both forward and reverse orientation, 4 reads calling the allele with a phred score of >20, and 75% allele frequency. After exclusion of multiple consecutive variant calls (in a 12 bp window), variants in drug resistance associated genes or repetitive regions, the remaining positions that had a clear base call for all strains and matched the above mentioned threshold levels in at least 95% of all strains were considered as valid, and combined in a concatenated sequence alignment. Mutations in drug resistance associated genes were analyzed separately but considering the same thresholds, as mentioned above.
Maximum Likelihood (ML) Phylogenetic Reconstruction and Molecular Clusters
A ML tree was calculated, based on the concatenated sequence alignment using FastTree (5) with a general time reversible (GTR) substitution model and 1,000 resamples. A molecular cluster was defined as >2 strains within a maximum genome wide distance of 5 single nucleotide polymorphisms (SNPs). In case another strain exceeded this threshold but shared a common ancestor with other clustered isolates; we indicated this in Figure 1and in Appendix 2 but did not considered these few cases for the cluster rates.
Comparison of Bacterial Demographic and Molecular Clock Models
For a temporal calibration of phylogenetic trees, we used BEAST 2.4.2 (6) and a concatenated sequence alignment of 6,512 SNPs discriminating all isolates.
Prior to model comparisons within the Bayesian statistical framework, we sought for a proper substitution model using jmodeltest 2.1 (based on maximum-likelihood estimates) (7).
Akaike and Bayesian information criteria (AIC and BIC) were considered for the identification of appropriate substitution models (Appendix 1 Table 2 ).
To compare a strict versus a relaxed clock model (assuming a constant population size), and different demographic models under the best clock model, we ran each analysis with 300 million steps, sampled 5,000 trees, and discarded 10% as burn-in, resulting in ESS values for all parameters in the hundreds and thousands. Marginal likelihood estimates for each run were computed using path sampling (included in the BEAST 2. Table 3 ).
Discrete Phylogeographical Analysis
The spatial and temporal expansion of MTBC strains belonging to the TUR genotype, Table 3 ). A Chain length of 300 million ignoring a burn-in of 10%, 5,000 trees sampled, resulted in ESS values for all parameters in the thousands. The temporal and geographic distribution was visualized with SPREAD (11) using Google Earth for location mapping of internal nodes and inferred location changes on the basis of a maximum clade credibility (MCC) tree.
Rationales for Determination of Likely Place of Infection
To identify a possible source/origin for the identified MDR TUR outbreak, i.e., nosocomial transmission versus a possible introduction of a regional-or community-acquired MDR strain type, we compared 2 hypotheses (1). One was of a fast TB progression, assuming that all patients receiving an MDR TB diagnosis at the national center for treatment of all psychiatric patients with concomitant respiratory illnesses Bela Crkva (BC Hospital) have been infected in BC Hospital itself when there was >1 month between admission and diagnosis. If the diagnosis was within the first month following admission at the BC Hospital, the initial hospital or the hometown of the patient was assumed as a likely place of infection (2) . The second hypothesis we used was a slow TB progression hypothesis: when MDR TB was diagnosed within the first 2 years after the admission to BC Hospital, we assumed that a patient had been infected elsewhere and was transferred as a latent TB case. The diagnosis after 2 years was considered as a healthcare-associated infection in BC Hospital. The geographic inference of place of infection for both hypotheses was used in the discrete phylogeographic analysis, and marginal likelihoods, inferred by path sampling, were compared as described above. *Two patients with clustered MDR-MTBC isolates were hospitalized both in Bela Crkva and Ozren. †Hospital for treatment of all psychiatric patients with concomitant respiratory illnesses in Serbia; ‡Hospital for the initial treatment phase of all patients diagnosed with tuberculosis and multidrug-resistant tuberculosis in Serbia.
